Dog /

Breed profile · FDA CVM July 2026 extract

Doberman Pinscher adverse-event record

Adverse-event filings for Doberman Pinscher (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#44 of 510
by report volume (all breeds)
4,631
FDA CVM reports on file
5.7%
death-coded share of reports
#107 of 275
by death-coded share (≥50 reports)

How the 4,631 reports break down

By recorded gender -- every report on file for Doberman Pinscher, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 313 234.75 156.5 78.25 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Doberman Pinscher drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Doberman Pinscher ranks #44 of 510 by total reports (4,631) and #107 of 275 by death-coded share (5.7%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#44
This breed, reports of 510
#107
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Doberman Pinscher has 4,631 reports now versus 4,575 in that prior snapshot: 56 more (1.2%).

Report change
+56
Death-coded reports
+2
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Doberman Pinscher changes

Total Reports

4,631

Highest-reported breed

Deaths Reported

264

of 4,631 reports

Death-coded share of reports

5.7%

Above-median death-coded share

Avg Age at Report

4.5 yr

33.9 kg avg weight

Breed Safety Scorecard

D (44/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate F
5.7%

Share of reports coded as a fatality

Euthanasia rate C-
2.1%

Share of reports resulting in euthanasia

Full recovery rate F
26.1%

Share of reports coded "Recovered/Normal"

5-year trend C-
+6%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Doberman Pinscher death-coded reports 5.7%
Cross-breed median

5.7% of 4,631 doberman pinscher reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Doberman Pinscher's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

6% 61st percentile Higher share than 61% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Doberman Pinscher 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Doberman Pinscher among report-volume vs. death-rate peers

Every breed shown has at least 50 filed reports. Volume reflects how often a breed is reported, not how common it is; death rate is the share of a breed's own reports coded as a death outcome.

Source: FDA openFDA Animal & Veterinary Adverse Events database 2×2 strategic matrix plotting 30 entities by Total Reports (X) and Death Rate (%) (Y), with a crosshair dividing the plot into four quadrants. High volume, high death rateLow volume, high death rateHigh volume, low death rateLow volume, low death rate 020,00040,00060,00080,000100,000 0%5%10%15% Total Reports Death Rate (%) Doberman Pinscher vs. all breeds, report volume and death-coded share Retriever - Labrador-93675, 3.7%Crossbred Canine/dog-70591, 3.2%Domestic Shorthair-65226, 7.2%Dog (unknown)-48820, 8.8%Retriever - Golden-35980, 3.7%Shepherd Dog - German-32220, 4.4%Chihuahua-31521, 4.2%Terrier - Yorkshire-24924, 3.7%Shih Tzu-24405, 3.6%Boxer (German Boxer)-19405, 4.4%Beagle-17970, 3.6%Pit Bull-17865, 3.1%Shepherd Dog - Australian-16274, 3.7%Terrier (unspecified)-14058, 3.1%Maltese-13940, 3.2%Dachshund (unspecified)-13512, 4.6%Cat (unknown)-13248, 9.3%Terrier - Jack Russell-10423, 3.7%Collie - Border-10130, 4.3%Siberian Husky-9811, 4.5%Domestic Longhair-9615, 7%Pug-9224, 5.2%Spitz - German Pomeranian-9086, 4.9%Terrier - Bull - American Pit-8769, 4.7%Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)-7871, 3.6%Terrier - Boston-7737, 4.5%Spaniel - Cocker American-7640, 4%Domestic (unspecified)-7576, 13.4%Poodle (unspecified)-7534, 3.4%Schnauzer - Miniature-7513, 4.4%
Source: FDA openFDA Animal & Veterinary Adverse Events database
Average weight at time of report: 33.9 kg (74.7 lbs)

Top Reported Reactions

Vomiting 717
Lack of efficacy (endoparasite) - heartworm 491
Diarrhoea 370
Emesis 347
INEFFECTIVE, HEARTWORM LARVAE 333
Lack of efficacy (endoparasite) - hookworm 326
Lethargy (see also Central nervous system depression in 'Neurological') 320
Lack of efficacy - NOS 307
Digestive tract disorder NOS 163
Anorexia 151
Death 142
Lack of efficacy (ectoparasite) - flea 136
Other abnormal test result NOS 129
Seizure NOS 115
Cardiac disorder NOS 113

Most Referenced Drugs

Milbemycin Oxime + Spinosad 848
Ivermectin + Pyrantel As Pamoate Salt 623
Afoxolaner 266
Moxidectin 260
Pyrantel Pamoate;Sarolaner 245
Milbemycin Oxime + Praziquantel 221
Spinosad 193
Carprofen 159
Fluralaner Chew Tablets 139
Oclacitinib Maleate 116
Bedinvetmab 104
Fluralaner 13.64% 12-Week Chew 101
Ivermectin/Pyrantel Pamoate Chewable 272Mcg/652Mg 84
Ivermectin, Pyrantel 80
Melarsomine Dihydrochloride 75

Outcome Breakdown

Outcome Unknown
1,441 (33.6%)
Recovered/Normal
1,210 (28.2%)
Ongoing
1,156 (27.0%)
Recovered with Sequela
214 (5.0%)
Died
171 (4.0%)
Euthanized
96 (2.2%)

Gender Distribution

Female 2,282 (49.3%)
Male 2,241 (48.4%)
Unknown 91 (2.0%)
Mixed 17 (0.4%)

Reports by Year

Year Reports Trend
2010 193
2011 213
2012 300
2013 337
2014 315
2015 328
2016 344
2017 335
2018 282
2019 273
2020 277
2021 255
2022 278
2023 280
2024 313
2025 270
2026 38

Doberman Pinscher: high-volume FDA adverse-event cohort

Signature read: 4,631 reports place Doberman Pinscher in the upper third of breed filing volume (#44 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Doberman Pinscher sits at #44 of 510 by report volume among all breeds and #38 of 298 among dog breeds, with 4,631 reports and 264 (5.7%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #107 of 275. Mean age at report: 4.5 years, average weight 33.9 kg (74.7 lbs).

Top reported signs: Vomiting (717), Lack of efficacy (endoparasite) - heartworm (491), Diarrhoea (370). Most-referenced drug: Milbemycin Oxime + Spinosad (848 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (623) and Afoxolaner (266).

Outcome coding on 4,288 status-recorded reports is dominated by Outcome Unknown (33.6%). Annual submissions ranged 38-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Doberman Pinscher drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (5.7% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (33.9 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Doberman Pinscher?
There are 4,631 adverse event reports involving Doberman Pinscher in the FDA database, of which 264 were death-coded (5.7% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Doberman Pinscher ranks #44 of 510 by report volume among all breeds PlainBreed indexes (#38 of 298 among dog breeds).
Where does Doberman Pinscher sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Doberman Pinscher is #44 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #38 of 298. Among breeds with at least 50 reports, its death-coded share ranks #107 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Doberman Pinscher?
The most commonly reported adverse reactions for Doberman Pinscher are Vomiting (717 reports), Lack of efficacy (endoparasite) - heartworm (491 reports), Diarrhoea (370 reports), Emesis (347 reports), INEFFECTIVE, HEARTWORM LARVAE (333 reports).
What drugs are most frequently associated with Doberman Pinscher adverse events?
The drugs most frequently referenced in Doberman Pinscher adverse event reports are Milbemycin Oxime + Spinosad (848 reports), Ivermectin + Pyrantel As Pamoate Salt (623 reports), Afoxolaner (266 reports), Moxidectin (260 reports), Pyrantel Pamoate;Sarolaner (245 reports).
What is the average age of Doberman Pinscher in adverse event reports?
The average age of Doberman Pinscher at the time of adverse event reports is 4.5 years, with an average weight of 33.9 kg (74.7 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Doberman Pinscher (Dog), extract as of July 2026 extract. 4,631 reports · 264 death-coded (5.7% of reports, not a mortality rate) · #44 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →